Ken Griffin

Ken Griffin Citadel Advisors

AUM $115B
1-Year Return 4.22%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Quarter Return
+2.1%
1 Year Return
+4.22%
3 Year Return
+14.25%
5 Year Return
+23%
10 Year Return
+57.51%
AUM
$115B
AUM Growth
+$13.1B
Cap. Flow
+$3.28B
Cap. Flow %
2.85%
Top 10 Hldgs %
8.55%
Holding
7,447
New
1,273
Increased
2,296
Reduced
2,131
Closed
1,385

Top Buys

1
NVDA icon
NVIDIA
NVDA
+$1.03B
2
MSFT icon
Microsoft
MSFT
+$928M
3
MCD icon
McDonald's
MCD
+$762M
4
AMZN icon
Amazon
AMZN
+$716M
5
KO icon
Coca-Cola
KO
+$650M

Sector Composition

1 Technology 16.69%
2 Healthcare 16.07%
3 Consumer Discretionary 12.79%
4 Financials 12.71%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EPRX
5201
Eupraxia Pharmaceuticals
EPRX
$189M
$108K ﹤0.01%
18,236
+6,182
+51% +$36.6K
PNI
5202
PIMCO New York Municipal Income Fund II
PNI
$77.8M
$106K ﹤0.01%
15,845
-1,907
-11% -$12.8K
ICL icon
5203
ICL Group
ICL
$7.83B
$106K ﹤0.01%
15,461
-340,904
-96% -$2.35M
JLHL
5204
Julong Holding Limited Class A Ordinary Shares
JLHL
$89.2M
$106K ﹤0.01%
+27,657
New +$106K
SOL
5205
Emeren Group
SOL
$97.5M
$106K ﹤0.01%
+56,572
New +$106K
SOND icon
5206
Sonder
SOND
$22.4M
$106K ﹤0.01%
+39,168
New +$106K
AEF
5207
abrdn Emerging Markets Equity Income Fund
AEF
$267M
$106K ﹤0.01%
+17,796
New +$106K
SGMO icon
5208
Sangamo Therapeutics
SGMO
$157M
$106K ﹤0.01%
195,261
-185,586
-49% -$100K
BAER icon
5209
Bridger Aerospace
BAER
$101M
$106K ﹤0.01%
+54,736
New +$106K
IBAC
5210
IB Acquisition Corp
IBAC
$167M
$105K ﹤0.01%
+10,072
New +$105K
RSSS icon
5211
Research Solutions
RSSS
$113M
$105K ﹤0.01%
36,728
+344
+0.9% +$987
GRAF
5212
Graf Global Corp.
GRAF
$302M
$105K ﹤0.01%
10,031
-2,114
-17% -$22.1K
ADFI icon
5213
Anfield Dynamic Fixed Income ETF
ADFI
$49.1M
$105K ﹤0.01%
+12,294
New +$105K
JEM
5214
707 Cayman Holdings Limited Ordinary Shares
JEM
$9.72M
$104K ﹤0.01%
+20,140
New +$104K
IPSC icon
5215
Century Therapeutics
IPSC
$42.3M
$104K ﹤0.01%
186,534
+177,425
+1,948% +$99.1K
DHY
5216
Credit Suisse High Yield Credit Fund
DHY
$218M
$104K ﹤0.01%
48,779
+12,201
+33% +$26K
NEUP
5217
Neuphoria Therapeutics Inc. Common Stock
NEUP
$23.5M
$104K ﹤0.01%
+14,606
New +$104K
NVFY icon
5218
Nova Lifestyle
NVFY
$119M
$104K ﹤0.01%
+74,508
New +$104K
YTRA icon
5219
Yatra Online
YTRA
$93.5M
$103K ﹤0.01%
105,747
-100,295
-49% -$97.7K
CRT
5220
Cross Timbers Royalty Trust
CRT
$46.7M
$103K ﹤0.01%
+10,416
New +$103K
NBH
5221
Neuberger Berman Municipal Fund
NBH
$310M
$103K ﹤0.01%
10,466
-1,300
-11% -$12.8K
FIGXU
5222
FIGX Capital Acquisition Corp. Units
FIGXU
$136M
$103K ﹤0.01%
+10,264
New +$103K
FEMY icon
5223
Femasys
FEMY
$12.1M
$103K ﹤0.01%
106,298
+64,282
+153% +$62.1K
GENVR
5224
Gen Digital Inc. Contingent Value Rights
GENVR
$102K ﹤0.01%
+12,520
New +$102K
GRCE
5225
Grace Therapeutics, Inc. Common Stock
GRCE
$42.7M
$102K ﹤0.01%
34,382
-4,021
-10% -$11.9K